National Healthcare Properties (NASDAQ:NHP) Raised to Hold at Zacks Research

National Healthcare Properties (NASDAQ:NHPGet Free Report) was upgraded by investment analysts at Zacks Research to a “hold” rating in a research note issued on Tuesday,Zacks.com reports.

Several other equities analysts also recently issued reports on the company. Citizens Jmp started coverage on National Healthcare Properties in a research report on Thursday, May 28th. They set a “market outperform” rating and a $18.00 price objective for the company. The Goldman Sachs Group started coverage on National Healthcare Properties in a research report on Monday, May 18th. They set a “buy” rating and a $20.00 price objective for the company. National Bank Financial set a $18.00 price objective on National Healthcare Properties in a research report on Thursday, May 28th. Morgan Stanley started coverage on National Healthcare Properties in a research report on Monday, May 18th. They set an “equal weight” rating and a $16.00 price objective for the company. Finally, Royal Bank Of Canada started coverage on National Healthcare Properties in a research report on Monday, May 18th. They set a “sector perform” rating and a $15.00 price objective for the company. Five equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $17.13.

Get Our Latest Stock Analysis on NHP

National Healthcare Properties Stock Down 0.8%

NHP stock opened at $13.98 on Tuesday. National Healthcare Properties has a fifty-two week low of $11.25 and a fifty-two week high of $15.40.

Featured Stories

Analyst Recommendations for National Healthcare Properties (NASDAQ:NHP)

Receive News & Ratings for National Healthcare Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Healthcare Properties and related companies with MarketBeat.com's FREE daily email newsletter.